 | Up a level |
Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Linde, Louise; Jacobsson, Lennart; Nissen, Michael J; Kristianslund, Eirik Klami; Santos, Maria José; Nordström, Dan; Rotar, Ziga; Gudbjornsson, Bjorn; Onen, Fatos; Codreanu, Catalin; Lindström, Ulf; Möller, Burkhard; Kvien, Tore K; Barcelos, Anabela; Eklund, Kari K; Tom, Matija; Love, Thorvardur Jon; Can, Gercek; ... (2024). Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - does it depend on the reason for withdrawal from the previous treatment? Joint bone spine, 91(4), p. 105729. Elsevier 10.1016/j.jbspin.2024.105729
Linde, Louise; Georgiadis, Stylianos; Ørnbjerg, Lykke M; Rasmussen, Simon H; Michelsen, Brigitte; Askling, Johan; Di Giuseppe, Daniela; Wallman, Johan K; Závada, Jakub; Pavelka, Karel; Bernardes, Miguel; Matos, Carolina O; Glintborg, Bente; Loft, Anne Gitte; Nordström, Dan; Kuusalo, Laura; Möller, Burkhard; Nissen, Michael J; Codreanu, Catalin; Mogosan, Corina; ... (2024). Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries. (In Press). Arthritis care & research Wiley 10.1002/acr.25396
Brahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michael J; Kristianslund, Eirik Klami; Mann, Herman; Santos, Maria José; Reino, Juan Gómez; Nordström, Dan; Rotar, Ziga; Gudbjornsson, Bjorn; Onen, Fatos; Codreanu, Catalin; Lindström, Ulf; Möller, Burkhard; Kvien, Tore K; Pavelka, Karel; Barcelos, Anabela; Sánchez-Piedra, Carlos; Eklund, Kari K; ... (2020). Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. Rheumatology, 59(7), pp. 1640-1650. Oxford University Press 10.1093/rheumatology/kez427
